Every founder falls in love with their idea, but the market does not care about your love. It cares about whether you remove a pain it already feels. A painkiller is something a customer needs badly enough to pay for it, switch tools for it, and adopt it even while your product is still rough. A vitamin is pleasant, improves things a little, and gets postponed the moment budgets or attention tighten. Scoping your MVP around a painkiller is the single highest-leverage decision you make before writing a line of code.
The difference in one sentence
A painkiller solves a problem your customer is already spending time or money trying to fix. A vitamin solves a problem they would fix only if it were free and effortless. The test is not how clever your product is. It is how much the customer hurts without it.
Signs you are building a vitamin
- Prospects say "nice" or "interesting" instead of "when can I have it."
- They enjoy the demo but will not name a date, a budget, or a person responsible for the problem.
- Your pitch has to first convince them that the problem even exists.
- They already tolerate the problem with a spreadsheet, a WhatsApp group, or a manual workaround, and feel fine about it.
- Nobody is currently paying anything, in money or effort, to solve it.
Painkillers show the opposite. People describe a workaround they hate, an existing budget line, and a deadline they cannot miss.
Ask these before you build
- What do they do today when this problem hits? If the answer is "nothing," the pain is probably mild.
- How often does it occur: daily, monthly, or once a year? Frequent pain sells. Rare pain rarely does.
- Who owns the problem and controls a budget for it? No owner usually means no urgency.
- What happens if they ignore it? Real painkillers carry a visible cost of inaction: lost revenue, penalties, wasted hours, or compliance risk.
For an Indian founder, some pains are structurally sharp. GST return deadlines, TDS compliance, delayed B2B payments, and blocked working capital create genuine urgency, because the cost of inaction is a penalty or a cash crunch rather than mere inconvenience. Those are fertile hunting grounds for painkillers.
Scope the MVP to the sharpest pain
Once you have found a painkiller, resist the urge to widen it. A first-time founder's instinct is to add features so the product appeals to everyone, but that turns a painkiller back into a vitamin, because a broad product relieves no single pain deeply. Do the opposite.
- Pick one user, one job, and one moment of pain.
- Build only what removes that pain end to end, even if everything around it stays manual for now.
- Charge for it early. Willingness to pay is the clearest proof that the pain is real.
- Say no to features that serve a different, milder pain.
Even seed capital rewards this discipline
This logic is baked into how India funds early startups. The Startup India Seed Fund Scheme (SISFS), run by DPIIT with an outlay of Rs. 945 crore, gives DPIIT-recognized startups up to Rs. 20 lakh as a grant for proof of concept, prototype development, or product trials, and up to Rs. 50 lakh through convertible debentures or debt for market entry, commercialization, or scaling. Eligibility requires a startup incorporated not more than two years earlier, with a product or service that has clear market fit and scope to scale. In other words, even a government seed grant is scoped around a real, fundable need, not a nice-to-have.
The takeaway
Before you build, earn a blunt answer to one question: if this product vanished tomorrow, would any customer chase you down to get it back? If yes, you are holding a painkiller. If they would simply shrug, you are holding a vitamin, and no amount of polish will change that. Find the pain first, scope your MVP tightly to it, and let willingness to pay confirm you were right.